- Featured News /
The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.
- Featured News /
NIBR translational immunologists and academic colleagues observe two distinct molecular patterns of disease progression in lung tissue samples.
- Featured News /
To celebrate International Women’s Day we explore how an inclusive environment that values unique and curious minds helps everyone be inspired to innovate every day.
- Featured News /
Learn how we’re working with partners like the International Agency for the Prevention of Blindness to eliminate preventable blindness.
- Featured News /
Novartis included in Dow Jones Sustainability World Index, with industry-leading performance in environmental and social reporting and human capital.
- Featured News /
September 29 is World Heart Day. For the past six decades, Novartis has been working to advance heart health around the world.
- Featured News /
At Novartis, we aim to be a leader in environmental sustainability and a catalyst for positive change both in our own operations and in our supply chain.
- Featured News /
AI offers the greatest potential to transform health systems from being reactive to proactive, predictive, and even preventive.
- Featured News /
European Medicines Agency (EMA) recently approved two European Novartis sites for commercial CAR-T manufacturing.
- Featured News /
Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond, a first in the healthcare industry.
Pagination
- ‹ Previous page
- 1
- …
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- …
- 277
- › Next page